- Kalera Public Limited Company (NASDAQ:KAL) has entered into a securities purchase agreement with a single institutional investor.
- The company will receive about $10.0 million through the private placement of 2.5 million shares and warrants.
- Each share is being sold together with accompanying warrants at a combined effective purchase price of $4.00.
- The closing of the private placement is expected to occur on July 11, 2022.
- Maxim Group LLC is acting as the sole placement agent for the offering.
- Price Action: KAL shares are trading higher by 8.16% at $4.77 on the last check Thursday.
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 15.41% on an annualized basis producing an average annual return of 23.37%. Currently, CRISPR Therapeutics has a market capitalization of $3.91 billion.
